Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease

NCT02843165 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer

Interventions

DRUG: Checkpoint blockade immunotherapy
RADIATION: Checkpoint blockade immunotherapy plus SBRT

Sponsor

University of California, San Diego